Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
BC Global Opportunities IX LP reported a 5.50% stake in Bridgebio Oncology Therapeutics, Inc. (Schedule 13G)
Event Sep 4, 2025 · Filed Sep 3, 2025
BC Global Opportunities IX LP reported a 5.50% stake in Bridgebio Oncology Therapeutics, Inc., 4,365,747 shares, as a passive investor on Sep 4, 2025. Filed Sep 3, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 4,365,747
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BC Global Opportunities IX LP | 5.50% | 4,365,747 |
| BC General Partner, LP | 5.50% | 4,365,747 |
| BC Capital Management Limited | 5.50% | 4,365,747 |
| Tan Kuangming | 5.50% | 4,365,747 |